HB1422 modifies Washington's drug take-back program by adjusting fees, enhancing oversight, and setting penalties for noncompliance.
HB1422 amends Washington's drug take-back program by adjusting fees, enhancing oversight, and setting penalties for noncompliance. The Department of Enterprise Services must set fees for program operators, which may not exceed actual administration, oversight, and enforcement costs. The department can assess civil fines of up to $2,000 for violations, such as failing to meet collection goals or not complying with program requirements. The bill also establishes a secure drug take-back program account for handling collected fees and fines.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.